Satellos Bioscience's market cap is currently $133.43M. The company's EPS TTM is C$-0.252; its P/E ratio is ―; Satellos Bioscience is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 25.00K
Gross Profit	C$ -8.82M	C$ -3.73M	C$ -119.92K	C$ -48.16K	C$ -1.26M
Operating Income	C$ -15.46M	C$ -8.43M	C$ -4.74M	C$ -1.55M	C$ -2.00M
EBITDA	C$ -15.71M	C$ -8.09M	C$ -4.60M	C$ -1.61M	C$ -2.00M
Net Income	C$ -15.89M	C$ -11.32M	C$ -15.51M	C$ -1.58M	C$ -1.99M
Balance Sheet
Cash & Short-Term Investments	C$ 39.59M	C$ 1.92M	C$ 4.87M	C$ 717.53K	C$ 399.13K
Total Assets	C$ 44.30M	C$ 6.20M	C$ 12.59M	C$ 1.13M	C$ 1.07M
Total Debt	C$ 0.00	C$ 0.00	C$ 0.00	C$ 1.09M	C$ 0.00
Net Debt	C$ -22.07M	C$ -1.92M	C$ -4.87M	C$ 375.78K	C$ -399.13K
Total Liabilities	C$ 3.62M	C$ 2.83M	C$ 2.10M	C$ 1.31M	C$ 664.81K
Stockholders' Equity	C$ 40.67M	C$ 3.37M	C$ 10.48M	C$ -183.84K	C$ 408.57K
Cash Flow
Free Cash Flow	C$ -14.52M	C$ -5.79M	C$ -5.04M	C$ -1.66M	C$ -1.93M
Operating Cash Flow	C$ -14.50M	C$ -5.78M	C$ -5.03M	C$ -1.66M	C$ -1.92M
Investing Cash Flow	C$ -17.54M	C$ -3.00K	C$ 1.74M	C$ 0.00	C$ -771.00
Financing Cash Flow	C$ 51.03M	C$ 2.77M	C$ 7.45M	C$ 1.98M	C$ 1.16M

Currency in CAD

Satellos Bioscience Earnings and Revenue History

Income Statement >

Satellos Bioscience Debt to Assets

Balance Sheet >

Satellos Bioscience Cash Flow

Cash Flow >

Satellos Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing